Associations between Alzheimer's disease biomarkers and postoperative delirium or cognitive dysfunction

被引:2
|
作者
Geng, Jun [1 ]
Zhang, Yaowen [1 ]
Chen, Hui [1 ]
Shi, Hui
Wu, Zhen [1 ]
Chen, Jianqing [1 ]
Luo, Foquan [2 ,3 ]
机构
[1] Nantong Univ, Dept Anaesthesiol, Jiangyin Hosp, Wuxi, Jiangsu, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Ctr Rehabil Med, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China
[3] Hangzhou Med Coll, Ctr Rehabil Med, Dept Anesthesiol, Zhejiang Prov Peoples Hosp,Affiliated Peoples Hosp, 158 Shangtang Rd, Hangzhou, Zhejiang, Peoples R China
关键词
CEREBROSPINAL-FLUID BIOMARKERS; MAJOR CARDIAC-SURGERY; TAU PHOSPHORYLATION; A-BETA; ALZHEIMERS-DISEASE; RATIO; PROTEIN; IMPAIRMENT; ACTIVATION; PREDICTS;
D O I
10.1097/EJA.0000000000001933
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUNDThe relationship between Alzheimer's disease biomarkers and postoperative complications, such as postoperative delirium (POD) and postoperative cognitive dysfunction (POCD), remains a subject of ongoing debate.OBJECTIVEThis meta-analysis aimed to determine whether there is an association between perioperative Alzheimer's disease biomarkers and postoperative complications.DESIGNWe conducted a meta-analysis of observational clinical studies that explored the correlation between Alzheimer's disease biomarkers and POD or POCD in patients who have undergone surgery, following PRISMA guidelines. The protocol was previously published (INPLASY: INPLASY202350001).DATA SOURCESA comprehensive search was conducted across PubMed, Embase, Web of Science, and Cochrane databases until March 2023.ELIGIBILITY CRITERIASurgical patients aged at least 18 years, studies focusing on POD or POCD, research involving Alzheimer's disease biomarkers, including A beta or tau in blood or cerebrospinal fluid (CSF), and availability of the full text.RESULTSOur meta-analysis included 15 studies: six focusing on POD and nine on POCD. The findings revealed a negative correlation between preoperative CSF beta-amyloid 42 (A beta 42) levels and the onset of POD [mean difference -86.1, 95% confidence interval (CI), -114.15 to -58.05, I2: 47%]; this association was strongly supported by trial sequential analysis (TSA). A similar negative correlation was discerned between preoperative CSF A beta 42 levels and the incidence of POCD (-165.01, 95% CI, -261.48 to -68.53, I2: 95%). The TSA also provided robust evidence for this finding; however, the evidence remains insufficient to confirm a relationship between other Alzheimer's disease biomarkers [beta-amyloid 40 (A beta 40), total tau (T-tau), phosphorylated tau (P-tau), and A beta 42/T-tau ratio] and POD or POCD.CONCLUSIONThe study results indicate a negative correlation between preoperative CSF A beta 42 levels and the occurrence of both POD and POCD. Future investigations are warranted to identify the predictive cutoff value of preoperative CSF A beta 42 for POD and POCD.
引用
收藏
页码:234 / 244
页数:11
相关论文
共 50 条
  • [31] Relationship between the postoperative delirium and dementia in elderly patients: Alzheimer's disease or vascular dementia
    Yoon, L.
    Ha, H. C.
    Noh, J. M.
    Hong, K. H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [32] Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease
    Carapelle, Elena
    Mundi, Ciro
    Cassano, Tommaso
    Avolio, Carlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 12
  • [33] Biomarkers Assessing Endothelial Dysfunction in Alzheimer's Disease
    Custodia, Antia
    Aramburu-Nunez, Marta
    Rodriguez-Arrizabalaga, Marina
    Pias-Peleteiro, Juan Manuel
    Vazquez-Vazquez, Laura
    Camino-Castineiras, Javier
    Aldrey, Jose Manuel
    Castillo, Jose
    Ouro, Alberto
    Sobrino, Tomas
    Romaus-Sanjurjo, Daniel
    CELLS, 2023, 12 (06)
  • [34] Retinal Dysfunction in Alzheimer's Disease and Implications for Biomarkers
    Liao, Chunyan
    Xu, Jinying
    Chen, Yu
    Ip, Nancy Y.
    BIOMOLECULES, 2021, 11 (08)
  • [35] Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer's Disease
    Hedderich, Dennis M.
    Drost, Rene
    Goldhardt, Oliver
    Ortner, Marion
    Mueller-Sarnowski, Felix
    Diehl-Schmid, Janine
    Zimmer, Claus
    Foerstl, Hans
    Yakushev, Igor
    Jahn, Thomas
    Grimmer, Timo
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [36] Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals
    Alemany, Silvia
    Crous-Bou, Marta
    Vilor-Tejedor, Natalia
    Mila-Aloma, Marta
    Suarez-Calvet, Marc
    Salvado, Gemma
    Cirach, Marta
    Arenaza-Urquijo, Eider M.
    Sanchez-Benavides, Gonzalo
    Grau-Rivera, Oriol
    Minguillon, Carolina
    Fauria, Karine
    Kollmorgen, Gwendlyn
    Gispert, Juan Domingo
    Gascon, Mireia
    Nieuwenhuijsen, Mark
    Zetterberg, Henrik
    Blennow, Kaj
    Sunyer, Jordi
    Luis Molinuevo, Jose
    ENVIRONMENT INTERNATIONAL, 2021, 157
  • [37] Multivariate MR biomarkers better predict cognitive dysfunction in mouse models of Alzheimer's disease
    Badea, Alexandra
    Delpratt, Natalie A.
    Anderson, R. J.
    Dibb, Russell
    Qi, Yi
    Wei, Hongjiang
    Liu, Chunlei
    Wetsel, William C.
    Avants, Brian B.
    Colton, Carol
    MAGNETIC RESONANCE IMAGING, 2019, 60 : 52 - 67
  • [38] Postoperative Cognitive Dysfunction and Alzheimer's Disease: A Transcriptome-Based Comparison of Animal Models
    Wang, Yi-Wei
    Wang, Liang
    Yuan, Sheng-Jie
    Zhang, Yuan
    Zhang, Xin
    Zhou, Le-Ting
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [39] Interplay Between Astroglial Endocannabinoid System and the Cognitive Dysfunction in Alzheimer's Disease
    Rapaka, Deepthi
    Adiukwu, Paul C.
    Challa, Siva Reddy
    Bitra, Veera Raghavulu
    PHYSIOLOGICAL RESEARCH, 2023, 72 (05) : 575 - 586
  • [40] EVALUATING THE ASSOCIATION BETWEEN MITOCHONDRIAL DYSFUNCTION AND COGNITIVE DECLINE IN ALZHEIMER'S DISEASE
    Adrien, Tamare
    Sonntag, Kai-Christian
    Cohen, Bruce
    Forester, Brent
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S126 - S127